These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34416083)

  • 1. Practical Consideration for Drug Monitoring of Tacrolimus in Liver Transplantation Recipients with SARS-CoV-2 Infection.
    Joshi T; Rana A; Vierling JM; Kanwal F; Goss JA; Cholankeril G
    Liver Transpl; 2022 Jan; 28(1):127-130. PubMed ID: 34416083
    [No Abstract]   [Full Text] [Related]  

  • 2. Tacrolimus: Unlikely Harmful and Perhaps Helpful in Liver Transplant Recipients with COVID-19.
    Pearson MM; Limaye AP; Biggins SW
    Gastroenterology; 2021 Mar; 160(4):1012-1013. PubMed ID: 33387518
    [No Abstract]   [Full Text] [Related]  

  • 3. COVID-19 in a young liver transplant recipient: caution for drug-drug interactions.
    Dajti E; Cristini F; Tamanini G; Cescon M; Bazzoli F; Tamè M
    J Gastrointestin Liver Dis; 2020 Sep; 29(3):470. PubMed ID: 32830825
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnosis and therapy of tacrolimus toxicity in a liver transplant recipient during COVID-19 treatment.
    Zhu F; Wang YM; Ni M; Liang Y; Huang JH; Wang XH; Cheng F; Lu L
    Hepatobiliary Pancreat Dis Int; 2024 Jun; 23(3):326-330. PubMed ID: 37852915
    [No Abstract]   [Full Text] [Related]  

  • 5. The case of a liver-transplant recipient with severe acute respiratory syndrome coronavirus 2 infection who had a favorable outcome.
    Hayashi K; Ito Y; Yamane R; Yoshizaki M; Matsushita K; Kajikawa G; Kozawa T; Mizutani T; Shimizu Y; Nagano K; Tachi K; Yoshioka K; Goto H
    Clin J Gastroenterol; 2021 Jun; 14(3):842-845. PubMed ID: 33675512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 infection in liver transplant recipients: A complex relationship.
    Alberca RW; Benard G; Alberca GGF; Sato MN
    World J Gastroenterol; 2021 Nov; 27(44):7734-7738. PubMed ID: 34908810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic Treatment of Transplant Recipients Infected With SARS-CoV-2: Considerations Regarding Therapeutic Drug Monitoring and Drug-Drug Interactions.
    Elens L; Langman LJ; Hesselink DA; Bergan S; Moes DJAR; Molinaro M; Venkataramanan R; Lemaitre F
    Ther Drug Monit; 2020 Jun; 42(3):360-368. PubMed ID: 32304488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humoral response to SARS-CoV-2 infection among liver transplant recipients.
    Becchetti C; Broekhoven AGC; Dahlqvist G; Fraga M; Zambelli MF; Ciccarelli O; Saouli AC; Trizzino A; Banz V; Dufour JF; Roukens AHE; Torres Morales SP; Myeni SK; Kikkert M; Feltkamp MCW; Coenraad MJ
    Gut; 2022 Apr; 71(4):746-756. PubMed ID: 34987065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of COVID-19 in Liver Transplant Recipients With Immunosuppressant Therapy: Experiences of an Iranian Transplant Registry.
    Sheikhalipour Z; Kermani TA; Kakaei F; Farshbaf Khalili A; Vahedi L
    Exp Clin Transplant; 2022 Mar; 20(3):285-292. PubMed ID: 34085915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 infection increases tacrolimus concentrations in solid-organ transplant recipients.
    Salerno DM; Kovac D; Corbo H; Jennings DL; Lee J; Choe J; Scheffert J; Hedvat J; Chen J; Tsapepas D; Rosenblatt R; Samstein B; Halazun K; Verna E; Pereira M; Brennan C; Husain SA; Mohan S; Brown RS
    Clin Transplant; 2021 Mar; 35(3):e14193. PubMed ID: 33336440
    [No Abstract]   [Full Text] [Related]  

  • 11. COVID-19 in long-term liver transplant patients: preliminary experience from an Italian transplant centre in Lombardy.
    Bhoori S; Rossi RE; Citterio D; Mazzaferro V
    Lancet Gastroenterol Hepatol; 2020 Jun; 5(6):532-533. PubMed ID: 32278366
    [No Abstract]   [Full Text] [Related]  

  • 12. Minimizing tacrolimus decreases the risk of new-onset diabetes mellitus after liver transplantation.
    Song JL; Gao W; Zhong Y; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Wu H; Xu MQ; Chen ZY; Wei YG; Jiang L; Yang J
    World J Gastroenterol; 2016 Feb; 22(6):2133-41. PubMed ID: 26877618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 infection in solid organ transplant recipients: A single-center experience with patients immediately after transplantation.
    Kolonko A; Dudzicz S; Wiecek A; Król R
    Transpl Infect Dis; 2021 Feb; 23(1):e13381. PubMed ID: 32578289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-drug interactions of ritonavir-boosted SARS-CoV-2 protease inhibitors in solid organ transplant recipients: experience from the initial use of lopinavir-ritonavir.
    Gonzalez-García R; Roma JR; Rodríguez-García M; Arranz N; Ambrosioni J; Bodro M; Castel MÁ; Cofan F; Crespo G; Diekmann F; Farrero M; Forner A; LLigoña A; Marcos MÁ; Moreno A; Ruiz P; Soy D; Brunet M; Miró JM; Tuset M
    Clin Microbiol Infect; 2023 May; 29(5):655.e1-655.e4. PubMed ID: 36641051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Past COVID-19 and immunosuppressive regimens affect the long-term response to anti-SARS-CoV-2 vaccination in liver transplant recipients.
    Toniutto P; Falleti E; Cmet S; Cussigh A; Veneto L; Bitetto D; Fornasiere E; Fumolo E; Fabris C; Sartor A; Peressutti R; Curcio F; Regattin L; Grillone L
    J Hepatol; 2022 Jul; 77(1):152-162. PubMed ID: 35283215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion of twice-daily to once-daily tacrolimus is safe in stable adult living donor liver transplant recipients.
    Kim SH; Lee SD; Kim YK; Park SJ
    Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):374-9. PubMed ID: 26256081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective Role of Tacrolimus, Deleterious Role of Age and Comorbidities in Liver Transplant Recipients With Covid-19: Results From the ELITA/ELTR Multi-center European Study.
    Belli LS; Fondevila C; Cortesi PA; Conti S; Karam V; Adam R; Coilly A; Ericzon BG; Loinaz C; Cuervas-Mons V; Zambelli M; Llado L; Diaz-Fontenla F; Invernizzi F; Patrono D; Faitot F; Bhooori S; Pirenne J; Perricone G; Magini G; Castells L; Detry O; Cruchaga PM; Colmenero J; Berrevoet F; Rodriguez G; Ysebaert D; Radenne S; Metselaar H; Morelli C; De Carlis LG; Polak WG; Duvoux C;
    Gastroenterology; 2021 Mar; 160(4):1151-1163.e3. PubMed ID: 33307029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tacrolimus Use and COVID-19 Infection in Patients After Solid Organ Transplantation.
    Yin S; Wang X; Song T
    Gastroenterology; 2021 Aug; 161(2):728-730.e1. PubMed ID: 33539863
    [No Abstract]   [Full Text] [Related]  

  • 19. Outcome of COVID-19 in liver transplant recipients: A preliminary report from Northwestern Italy.
    Patrono D; Lupo F; Canta F; Mazza E; Mirabella S; Corcione S; Tandoi F; De Rosa FG; Romagnoli R
    Transpl Infect Dis; 2020 Oct; 22(5):e13353. PubMed ID: 32500942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart and liver transplant recipients from donor with positive SARS-CoV-2 RT-PCR at time of transplantation.
    de la Villa S; Valerio M; Salcedo M; Ortiz-Bautista C; Catalán P; Padilla B; Romero M; Blázquez-Bermejo Z; Pedraz Á; López-Baena JÁ; Hortal J; Bouza E; Alonso R; Muñoz P
    Transpl Infect Dis; 2021 Oct; 23(5):e13664. PubMed ID: 34092025
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.